Cite
HARVARD Citation
Colombo, N. et al. (2022). Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. Obstetrical & gynecological survey. 77 (1), pp. 30-31. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Colombo, N. et al. (2022). Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. Obstetrical & gynecological survey. 77 (1), pp. 30-31. [Online].